Cite
HARVARD Citation
Nywening, T. et al. (n.d.). Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet oncology. 17 (5), pp. 651-662. [Online].